small molecule

DESONIDE

DESONIDE

Loss of exclusivityloss of exclusivity
CompanyPADAGIS US LLC

Drug detail

Brand nameDESONIDE
Active ingredientDESONIDE
Strength0.05%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DESONIDE patent cliff — loss of exclusivity — | CliffBio